David Caudell to Hematopoietic Stem Cells
This is a "connection" page, showing publications David Caudell has written about Hematopoietic Stem Cells.
Connection Strength
0.029
-
Cook GJ, Caudell DL, Elford HL, Pardee TS. The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML. PLoS One. 2014; 9(11):e112619.
Score: 0.029
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.